Transcriptomic profiling of the immune responses of immune-competent adult progressors versus non-TB progressors in a well-characterized TB case-contact platform from The Gambia identified—among others—antiapoptotic gene BCL2 as a marker that might predict the onset of active disease very early after infection (11). The gene discussed is BCL2; the disease is tuberculosis.